We appreciate our readers’ patience as we defer our oil analysis by one more day and we are committed to publishing it tomorrow morning. That said, the situation is fairly clear at this stage: one of the most critical regions in the world for energy production — including natural gas, which should not be overlooked […]
Yesterday’s session, ahead of the highly anticipated earnings release from NVIDIA—as is often the case, among the last of the mega-cap names to report this season—was characterized by a solid rebound, finally led by the Technology sector. Major U.S. equity indices advanced between +0.7% and +1.1%. Overnight, both South Korea and Taiwan equity indices—widely regarded […]
It has not been a good month so far for the US500 (S&P 500), and we are only on February 17. The index’s month-to-date performance currently stands at -1.48%, which has also pushed the year-to-date return into negative territory (-0.33% as of last Friday’s close at 6,836). This morning, following yesterday’s market holiday, the index […]
As of yesterday’s close, the S&P 500 is up 15.62% year to date. This performance is broadly consistent with the long-standing assumption that, over the long run, the index that best “represents” the market tends to deliver average annual returns of around 10%. This may help explain why, for several weeks now, we have no […]
On Friday, 21 November 2025, Eli Lilly became the first pharmaceutical company to reach a valuation typically reserved for major technology giants: USD 1 trillion. The milestone was achieved when its share price hit $1,057.78. Alongside Big Tech, the company now trades at valuations that—while elevated, as we will see shortly—many analysts consider justified by […]
This website is not intended for residents of the European Union and operates outside the scope of the MiFID II regulatory framework. By selecting the option below, you confirm that you understand this notice and wish to proceed to OnEquity.
